It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
They also discovered that cigarette use declined among a subgroup of smokers in the study, lending weight to the hypothesis ...
As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...
RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...
Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several people who developed eye conditions soon after they began taking semaglutide ...